Thriva, a London, UK-based digital health startup, raised £1.5m in seed funding.
The round includes Alex Chesterman, founder and CEO of Zoopla, Taavet Hinrikus, CEO and founder of TransferWise, as well as early stage venture funds Seedcamp, 500 Startups and the London Co-Investment Fund (LCIF).
The company will use the funds to expand their product range and will soon be able to analyze a variety of health markers from gut health to heavy metals to hormones.
Launched in 2016 and led by Hamish Grierson, CEO, Thriva is a digital health startup that is advancing a finger-prick blood test to be done at home, with results within 48 hours, and a dashboard to track health changes over time.
Users can:
1) Get a Thriva kit, by signing up online.
2) Once the kit arrives, take the test and pop the sample in the post with pre-paid mailer.
3) Results are delivered within 48 hours on a personal online dashboard along with GP recommendations on how best to understand and act upon them.
Thriva provides a range of tests, including its popular subscription service Baseline. The quarterly test monitors and tracks cholesterol levels, Vitamin-D deficiency, iron deficiency and poor liver function.
FinSMEs
13/06/2017